argenx SE reported $50.99B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AstraZeneca USD 289.99B 11.26B Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
UCB EUR 46.41B 13.94B Dec/2025